0001225208-22-007153.txt : 20220518 0001225208-22-007153.hdr.sgml : 20220518 20220518162734 ACCESSION NUMBER: 0001225208-22-007153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kooyman John W CENTRAL INDEX KEY: 0001765088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 22939488 MAIL ADDRESS: STREET 1: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0306 4 2022-05-16 0000021665 COLGATE PALMOLIVE CO CL 0001765088 Kooyman John W C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 Chief of Staff Common Stock 2022-05-16 4 M 0 19683.0000 72.9900 A 26690.0000 D Common Stock 2022-05-16 4 S 0 19683.0000 78.4936 D 7007.0000 D Common Stock 10336.0000 I By Issuer's 401(k) Plan Trustee Stock Option (Right to Buy) 72.9900 2022-05-16 4 M 0 19683.0000 0.0000 D 2022-09-08 Common Stock 19683.0000 0.0000 D Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $78.49 to $78.495, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2022-05-18